Eye camera showdown: can new tech match the gold standard?

NCT ID NCT06380075

Recruiting now Knowledge-focused Sponsor: University of Wisconsin, Madison Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study compares two new ultrawide field cameras (Clarus and Optos) to the standard Spectralis camera for taking pictures of the back of the eye in people with inherited retinal diseases. Fifty adults will have their eyes dilated and photographed with all three cameras. The goal is to see if the newer cameras provide the same quality images for monitoring disease progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could show that newer, wider-angle cameras are just as good as the standard for monitoring inherited retinal diseases, potentially improving convenience for patients.
What could go wrong: This is a small, early-stage observational study (50 participants) comparing imaging devices, not testing a treatment. The results may not apply to all patients or diseases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INHERITED RETINAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

inherited retinal dystrophy retinal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RETINAL DISEASE

Contacts and locations

Locations

Department of Ophthalmology and Visual Sciences
RECRUITING

Madison, Wisconsin, 53705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.